Quirijn

van Veen

QV

About

Quirijn

Quirijn is a partner at INGEN HOUSZ.  He focuses on venture capital investments both early and late stage and M&A transactions. Previously Quirijn worked as a lawyer at the corporate section of Freshfields Bruckhaus Deringer. He also worked at the M&A team of Solvay in Brussels and at start-up Plugify.


He is the founder of a successful negotiations program in Amsterdam, teaching the principles of negotiations to young professionals. Quirijn studied private law at the University of Amsterdam. He also studied in New York on a tennis scholarship.

His expertises

Her expertises

Their expertises

Their expertises

Venture capital investments

M&A transactions

Her work includes:

His work includes:

Their work includes:

Newion and Simon Capital lead €6m round in Neople

2024

2024-06-04

Accel invests in Swypex

2024

2024-05-13

Vitestro raises $22m in round co-led by Sonder Capital and NYBC Ventures, with participation from Invest-NL, the EIC Fund and private investors

2024

2024-04-30

Moove secures $100m Series B funding

2024

2024-03-19

Monumental attracts $25m funding in round led by Plural and Hummingbird with participation of Northzone, Foundamental and NP-Hard Ventures

2024

2024-02-15

World Fund and Vorwerk Ventures lead investment round in Farmless

2023

2023-12-05

Rubio Impact Ventures and Educapital co-lead a €10.3M Series A investment round in Female Invest, with co-investment from Sparkmind.vc.

2024

2024-07-29

Northzone leads €9M investment round in Solvimon

2023

2023-11-13

His most recent work:

Her most recent work:

Their most recent work:

16/1/25

Workwize attracts $13m Series A funding

IH acted for Workwize
12/12/24

Keen Venture Partners and Day One Capital lead investment round in Perciv AI

IH acted for Perciv AI
5/12/24

Alveron Pharma attracts €5m seed extension round

IH acted for Alveron Pharma 
16/1/25

Workwize attracts $13m Series A funding

IH acted for Workwize
12/12/24

Keen Venture Partners and Day One Capital lead investment round in Perciv AI

IH acted for Perciv AI
5/12/24

Alveron Pharma attracts €5m seed extension round

IH acted for Alveron Pharma